
Traditional Medicare to add prior authorizations
Medicare is requiring more pre-treatment approvals in its fee-for-service program in a bid to root out unnecessary care, federal regulators announced Friday.
The big picture: Traditional Medicare historically hasn't required prior authorizations to access most drugs or services, a major perk for enrollees.
Prior authorization in privately-run Medicare Advantage plans has become a hot-button issue, with Congress and federal regulators working to rein in the practice. Federal inspectors found in 2022 that prior authorization in MA prevented some seniors from getting medically necessary care.
Major health insurers this week made a voluntary pledge to streamline and improve the prior authorization process across all health insurance markets.
State of play: Medicare's innovation center announced that it will solicit applications from companies to run the prior authorization program.
Medicare is looking for companies with experience using AI and other tools to manage pre-approvals for other payers, and with clinicians who can conduct medical reviews to check coverage determinations.
The program will start Jan. 1, 2026 and run through the end of 2031.
It will only apply to providers and patients in New Jersey, Ohio, Oklahoma, Texas, Arizona and Washington.
The change will apply to 17 items and services, including skin substitutes, deep brain stimulation for Parkinson's Disease, impotence treatment and arthroscopy for knee osteoarthritis.
CMS selected the services based on previous reports and evidence of fraud, waste and abuse, as well as what's already subject to prior authorization in Medicare Advantage.
Overuse of skin substitutes to help heal wounds has especially come under fire in recent years. Medicare spent more than $10 billion on the products in 2024 — more than double what was spent the year before, according to the New York Times.
CMS noted that it may make other services subject to the prior authorization program in future years.
Providers in the geographic areas can choose whether or not they want to submit an authorization request before delivering a service. But if they decide not to, they'll be subject to post-claim review and risk not getting paid for a service that was already delivered.
"In general, this model will require the same information and clinical documentation that is already required to support Medicare FFS payment but earlier in the process, namely, prior to the service being furnished," the notice reads.
Zoom in: The companies hired to manage the program will be paid based on how much they saved the government by stopping payments for unnecessary services.
"Under the model, we will work to avoid any adverse impact on beneficiaries or providers/suppliers," CMS wrote in the notice.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
3 hours ago
- Bloomberg
Trump Speeds Up Tax Bill Deadline as Tentative SALT Deal Reached
By and Erik Wasson Updated on Save President Donald Trump amped up pressure on Congress to speed passage of his tax-cut bill as Republicans reached a tentative deal on the state and local tax deduction, one of the key sticking points in the negotiations. 'The House of Representatives must be ready to send it to my desk before July 4th — We can get it done,' Trump said on Truth Social Friday.


Business Insider
5 hours ago
- Business Insider
Chemed provides update on 2025 performance in Q2 preannouncement
Chemed (CHE) announced developments related to Q2 earnings and FY25 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarterly earnings update, VITAS internal projections showed that the Florida consolidated program would end the 2025 government fiscal year ending on September 30, 2025 with a Medicare Cap cushion. Actual Medicare admissions in both April and May 2025 in Florida were weaker than anticipated and lower than VITAS' internal projections. As a result, VITAS now projects a Medicare Cap revenue limitation for the 2025 Cap Year of $18M-$25M related to the Florida consolidated program, excluding Tallahassee. The above projection includes actual results through May. Actual June results, which show better admissions than projected through the first half of the month, and actual results in Q3 could have a significant impact on this projection. Previous guidance for 2025 earnings did not include any Florida Medicare Cap. Based on the new start locations in Florida, primarily Marion County and Pinellas County, combined with operational changes currently being made in the Florida programs, management expects not to have any significant level of Medicare Cap revenue limitation in its Florida consolidated program for the 2026 fiscal year. This expectation assumes that the rate differential discussed above does not recur for the 2026 Cap Year. In the event that the rate differential does recur, VITAS will respond with further mitigation strategies at the outset of the 2026 Cap Year. While less financially significant than the VITAS Medicare Cap situation, during Q2, Roto-Rooter began to experience unexpected weakness in its residential business' demand compared to internal projections. This weakness represents a break from the trends experienced in Q1. Preliminary results for commercial demand in Q2 continue to reflect improved trends but not enough to offset the lower residential demand.

Wall Street Journal
7 hours ago
- Wall Street Journal
The Power of Positive Thinking about Deregulation
Economic growth was negative in the first quarter, government-imposed costs on trade have risen this year, federal debt continues to soar, stocks are richly priced relative to their earnings, and Congress is laboring just to prevent massive tax hikes scheduled for the end of the year. Yet equity investors keep expressing confidence in U.S. business. The Journal's Karen Langley and Krystal Hur report: